The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community

Vaccine

Volumn 29, Issue 1, 2010, Pages 91-94

  Muhsen, Khitam ^a   Chodick, Gabriel ^a,b   Goren, Sophy ^a   Shalev, Varda ^a,b   Cohen, Dani ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MACCABI HEALTHCARE SERVICES   (Israel)

Author keywords

Acute gastroenteritis; Effectiveness; Physician visits; Rotavirus vaccines

Indexed keywords

ROTAVIRUS VACCINE;

ACTIVE IMMUNIZATION; ACUTE GASTROENTERITIS; ARTICLE; CHILD; COHORT ANALYSIS; COMMUNITY CARE; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL; ROTAVIRUS; SOCIAL STATUS; THERAPY EFFECT; VACCINATION;

COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GASTROENTERITIS; HUMANS; INFANT; ISRAEL; MALE; OFFICE VISITS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 78649695271     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.010     Document Type: Article

References (18)

1. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354(1):11-22.
2. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(1):23-33.
3. Glass R.I., Parashar U.D., Bresee J.S., Turcios R., Fischer T.K., Widdowson M.A., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006, 368(9532):323-332.
4. Centers for Disease Control and Prevention. Delayed onset and diminished magnitude of rotavirus activity - United States, November 2007-May 2008. MMWR Morb Mortal Wkly Rep 2008;57(25):697-700.
5. Parashar U.D., Glass R.I. Rotavirus vaccines - early success, remaining questions. N Engl J Med 2009, 360(11):1063-1065.
6. Marshall H, Clarke M, Davidson G, Gold M, Rasiah K. Impact of rotavirus vaccination on paediatric gastroenteritis admissions in South Australia. In: Vaccines for enteric diseases. Malaga, Spain; 2009. p. 137.
7. Tate J.E., Panozzo C.A., Payne D.C., Patel M.M., Cortese M.M., Fowlkes A.L., et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009, 124(2):465-471.
8. Clark H.F., Lawley D., Mallette L.A., DiNubile M.J., Hodinka R.L. Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine. Clin Vaccine Immunol 2009, 16(3):382-386.
9. Correia J.B., Patel M.M., Nakagomi O., Montenegro F.M., Germano E.M., Correia N.B., et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P [4] strains in Brazil. J Infect Dis 2010, 201(3):363-369.
10. World Health Organization. Weekly Epidemiological Record 2009;84(23):213-36.
11. Boom J.A., Tate J.E., Sahni L.C., Rench M.A., Hull J.J., Gentsch J.R., et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010, 125(2):e199-e207.
12. Patel M., Pedreira C., De Oliveira L.H., Tate J., Orozco M., Mercado J., et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009, 301(21):2243-2251.
13. Muhsen K., Shulman L., Rubinstein U., Kasem E., Kremer A., Goren S., et al. Incidence, characteristics, and economic burden of rotavirus gastroenteritis associated with hospitalization of Israeli children <5 years of age, 2007-2008. J Infect Dis 2009, 200(Suppl. 1):S254-S263.
14. Muhsen K., Shulman L., Kasem E., Rubinstein U., Shachter J., Kremer A., et al. Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control study. Hum Vaccin 2010, 6(6).
15. Zaman K., Dang D.A., Victor J.C., Shin S., Yunus M., Dallas M.J., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376(9741):615-623.
16. Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010, 362(4):289-298.
17. Armah G.E., Sow S.O., Breiman R.F., Dallas M.J., Tapia M.D., Feikin D.R., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376(9741):606-614.
18. Serazin A.C., Shackelton L.A., Wilson C., Bhan M.K. Improving the performance of enteric vaccines in the developing world. Nat Immunol 2010, 11(9):769-773.